We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cell Culture
Interview with Erik Vaessen About the Oceo Rover
In this recorded interview, Erik Vaessen, Chief Business Officer – Life Sciences, presents our latest innovation, Oceo Rover - the first and only Read more...New European Facility Q&A with Erik Vaessen, PhD, Executive Director, Life Sciences, FUJIFILM Irvine Scientific
Erik Vaessen, PhD, Executive Director, Life Sciences, FUJIFILM Irvine Scientific
This fall, FUJIFILM Irvine Scientific will open our third manufacturing Read more...Cell Culture Media Suppliers: Regulatory Considerations for Advanced Therapies
What are the regulatory challenges and opportunities that exist in media production for cell and gene therapies? In this webinar, Marlin Frechette, Corporate Read more...Regulatory Considerations for Raw Material Quality and Testing
What are the regulations and requirements that raw material suppliers need to understand to develop commercially viable advanced therapies? In a discussion led by Read more...Media Development and Optimization for Your Custom Cell Culture Needs
FUJIFILM Irvine Scientific discusses FAQ around custom media development
Custom cell culture media can be critical to optimizing bioproduction, and enable Read more...BioInformant Goes Behind the Scenes at FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific CEO Yutaka Yamaguchi interviewed by Bioinformant
Yutaka Yamaguchi, CEO of FUJIFILM Irvine Scientific, was recently invited to sit down Read more...Leading Industry Experts Address Cell and Gene Therapy Raw Materials Supply Chain Needs
Recently Marlin Frechette, FUJIFILM Irvine Scientific's Sr. Director of Quality Systems/Regulatory Affairs/Compliance Officer & ISO Management Representative, Read more...Cell Culture Experts Share Insights and Look into the Future of Media Development
Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific recently participated in a panel discussion among cell culture media experts about current Read more...Cohesive Control of Antibody Galactosylation for Improved Antibody Product Quality and Function
Protein-based therapeutics are dominating the pharmaceutical market due to their high-efficacy in treating complex diseases.1 The demand for antibody (Ab) drugs Read more...Cell, Media, and Process – The Three Musketeers of Cell Culture
Optimal cell culture performance requires the cells, the media, and the process all work together closely in harmony. Much like the legendary Three Musketeers from Read more...
Recent Posts
-
Meet the Team: Interview with Robert Hodge – Senior Director, Corporate Planning - Interview with Erik Vaessen About the Oceo Rover
-
Meet the Team: Interview with Tony Bernardino – Associate Sales Director, Life Sciences -
Optimize, Automate, and Scale Closed-System MSC Expansion -
Manufacturing IVF Media – Quality from Beginning to End
